CRI Report: brain disease modalities and software market is projected to reach $21,867.6 million by 2031
The global brain disease modalities and software market is projected to reach $21,867.6 million by 2031, reveals the premium market intelligence study by Our Research Team. The study also highlights that the market is set to witness a CAGR of 5.31% during the period 2022-2031.
Read More